ArticleJCO oncology advances2026

Prescribing patterns and real-world clinical usage of adjuvant abemaciclib for early-stage, high-risk, hormone receptor-positive breast cancer.

Sneha Rajendran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.